Phase III APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P + Gem) versus gemcitabine (Gem) alone for patients with resected pancreatic cancer (PC): Outcomes by geographic region Meeting Abstract
| Authors: | Reni, M.; Riess, H.; O'Reilly, E. M.; Park, J. O.; Hatoum, H.; Saez, B. L.; Salminen, T.; Oettle, H.; Lopez, R.; Dowden, S. D.; Karthaus, M.; Tabernero, J.; Van Cutsem, E.; Philip, P. A.; Goldstein, D.; Berlin, J.; Tempero, M. A. |
| Abstract Title: | Phase III APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P + Gem) versus gemcitabine (Gem) alone for patients with resected pancreatic cancer (PC): Outcomes by geographic region |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368302136 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.4515 |
| Notes: | Meeting Abstract: 4515 -- Source: Wos |
